Dynamic Medical Technologies Asset Resilience Ratio
Dynamic Medical Technologies asset resilience ratio. Dynamic Medical Technologies (4138) has an Asset Resilience Ratio of 19.86% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Dynamic Medical Technologies (4138) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Dynamic Medical Technologies (2016–2025)
Asset resilience ratio of Dynamic Medical Technologies from 2016 to 2025. This chart shows how Dynamic Medical Technologies's Asset Resilience Ratio has changed over time. Read how much debt does Dynamic Medical Technologies carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Dynamic Medical Technologies's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Dynamic Medical Technologies.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$625.70 Million | 19.86% |
| Total Liquid Assets | NT$625.70 Million | 19.86% |
Asset Resilience Insights
- Good Liquidity Position: Dynamic Medical Technologies maintains a healthy 19.86% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Dynamic Medical Technologies Industry Peers by Asset Resilience Ratio
Compare Dynamic Medical Technologies's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Dynamic Medical Technologies Asset Resilience Ratio by Year (2016–2025)
Dynamic Medical Technologies asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Dynamic Medical Technologies.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 18.54% | NT$579.70 Million ≈ $18.26 Million |
NT$3.13 Billion ≈ $98.51 Million |
-1.87pp |
| 2024-12-31 | 20.41% | NT$613.25 Million ≈ $19.32 Million |
NT$3.00 Billion ≈ $94.65 Million |
-0.33pp |
| 2023-12-31 | 20.75% | NT$638.36 Million ≈ $20.11 Million |
NT$3.08 Billion ≈ $96.94 Million |
-0.94pp |
| 2022-12-31 | 21.69% | NT$581.46 Million ≈ $18.32 Million |
NT$2.68 Billion ≈ $84.47 Million |
+0.28pp |
| 2021-12-31 | 21.41% | NT$492.09 Million ≈ $15.50 Million |
NT$2.30 Billion ≈ $72.42 Million |
+0.53pp |
| 2020-12-31 | 20.88% | NT$447.35 Million ≈ $14.09 Million |
NT$2.14 Billion ≈ $67.51 Million |
-0.19pp |
| 2019-12-31 | 21.07% | NT$468.65 Million ≈ $14.77 Million |
NT$2.22 Billion ≈ $70.08 Million |
+12.15pp |
| 2018-12-31 | 8.92% | NT$180.02 Million ≈ $5.67 Million |
NT$2.02 Billion ≈ $63.61 Million |
-5.39pp |
| 2017-12-31 | 14.31% | NT$330.60 Million ≈ $10.42 Million |
NT$2.31 Billion ≈ $72.78 Million |
-0.74pp |
| 2016-12-31 | 15.05% | NT$341.62 Million ≈ $10.76 Million |
NT$2.27 Billion ≈ $71.49 Million |
-- |
About Dynamic Medical Technologies
Dynamic Medical Technologies Inc., together with its subsidiaries, engages in the sale, maintenance, and marketing of aesthetic lasers and light-based equipment in Taiwan and Hong Kong. It distributes and sells aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The company also provides aesthetician training and clinical operation consultation services. In add… Read more